Domestic firms’ strategic alliance with multinational firms bring no benefits

A number of domestic pharmaceutical firms already established strategic alliances with multinational firms here, in a desperate efforts to boost sales to soften the hardest impacts caused by the govement-mandated cuts in drug price, but their margin profits seem to be negligible, a market source said.

Data released by Yakup Shinmoon, a pharmaceutical trade paper, some of leading pharmaceutic...